Clinical Trial Update: Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining how GCF levels of sclerostin and DKK-1 change in postmenopausal osteoporosis, completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Periodontitis

Snippet

Sponsor: Ondokuz Mayıs University | Conditions: Osteoporosis, Postmenopausal, Periodontitis | Phase 4 | Status: COMPLETED | Results posted: 2020-12-01